-
Population-Level Impact Assessment of the Revised Dyslipidemia Prescription Protocol in Greece Using Simulation Modeling
Sep 9, 2025, 16:22 PM -
Costs and Their Impacts That Should Be Included in Health Technology Assessment of Remote Palliative Care
Sep 9, 2025, 16:22 PM -
Confirmation of Diagnosis Method for Robust Participant Selection in Direct-to-Patient Real-World Evidence Studies
Sep 9, 2025, 16:22 PM -
The Costs of Loneliness-Related Health Consequences in Finland
Sep 9, 2025, 16:22 PM -
Estimating Rare Disease Incidence and Prevalence of Essential Thrombocythemia in Major Health Plans in the United States
Sep 9, 2025, 16:22 PM -
NMAs of Systemic Therapies for Advanced Biliary Tract Cancer: A Systematic Review and Critical Appraisal Using RoB NMA
Sep 9, 2025, 16:22 PM -
Pharmacists’ Engagement With Pharmaceutical Care in Pakistan: Insights From a Cross-Sectional Survey on Knowledge, Attitudes, Practices, and Barriers
Sep 9, 2025, 16:22 PM -
Leveraging Large Language Models and EMR Data to Identify Undiagnosed Rare Diseases: A Hybrid AI Approach
Sep 9, 2025, 16:22 PM -
Epidemiology of Diabetes Mellitus in Pregnancy in Hungary: Trends and Future Projections
Sep 9, 2025, 16:22 PM -
Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada
Sep 9, 2025, 16:22 PM -
Comparing Countries’ Time to Treatment Initiation: A Study of Metastatic Breast Cancer in Austria and the United States
Sep 9, 2025, 16:22 PM -
A Systematic Review and Network Meta Analysis of Pharmacologic Disease-Modifying Therapies for Early Alzheimer's Disease
Sep 9, 2025, 16:22 PM -
Examining the Trade-off of Breastfeeding vs. Semaglutide Use After Childbirth
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Prognostic Factors in Advanced Merkel Cell Carcinoma
Sep 9, 2025, 16:22 PM -
Beyond RCTs: The Role of Patient Perspectives and Nontraditional Evidence in HTA Decisions for Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data
Sep 9, 2025, 16:22 PM -
Population-Level Impact of Emicizumab in Algeria: A 25-Year Projection
Sep 9, 2025, 16:22 PM -
Generative A-Powered Extraction of Immune-Related Adverse Events From Oncology Case Reports
Sep 9, 2025, 16:22 PM -
The SISAQOL-IMI Recommendations on Standardizing the Use of Thresholds for Interpretation of Patient-Reported Outcome Results in Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset
Sep 9, 2025, 16:22 PM
